Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Hepatitis C

  Free Subscription


1 Haemophilia
1 J Gen Virol
3 J Infect Dis
3 J Viral Hepat
3 PLoS One
1 Transplantation

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. TER-ZAKARIAN A, Barnes RFW, Kruse-Jarres R, Quon DV, et al
    Blood pressure in persons with haemophilia with a focus on haemophilia-specific risk factors.
    Haemophilia. 2022;28:977-985.
    PubMed         Abstract available

    J Gen Virol

  2. CHUMBE A, Urbanowicz RA, Sliepen K, Koekkoek SM, et al
    Optimization of the pseudoparticle system for standardized assessments of neutralizing antibodies against hepatitis C virus.
    J Gen Virol. 2022;103.
    PubMed         Abstract available

    J Infect Dis

  3. VETTER BN, Reipold EI, Ongarello S, Audu R, et al
    Sensitivity and Specificity of Rapid Diagnostic Tests for Hepatitis C Virus With or Without HIV Coinfection: A Multicentre Laboratory Evaluation Study.
    J Infect Dis. 2022;226:420-430.
    PubMed         Abstract available

  4. OGAWA E, Nomura H, Nakamuta M, Furusyo N, et al
    Development of Hepatocellular Carcinoma in Patients Aged 75-84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals.
    J Infect Dis. 2022;226:431-440.
    PubMed         Abstract available

  5. KITABAYASHI J, Shirasaki T, Shimakami T, Nishiyama T, et al
    Upregulation of the Long Noncoding RNA HULC by Hepatitis C Virus and Its Regulation of Viral Replication.
    J Infect Dis. 2022;226:407-419.
    PubMed         Abstract available

    J Viral Hepat

  6. PERAZZO H, Silva MST, Coutinho C, Peixoto EM, et al
    Monkeypox outbreak as an opportunity to identify new cases of HCV infection in limited resource settings.
    J Viral Hepat. 2022 Nov 10. doi: 10.1111/jvh.13771.

  7. YANG AH, Yardeni D, Hercun J, Kleiner DE, et al
    Shear Wave Elastography: How well does it perform in Chronic Hepatitis D Virus Infection?
    J Viral Hepat. 2022 Sep 5. doi: 10.1111/jvh.13745.
    PubMed         Abstract available

  8. FELD JJ, Forns X, Dylla DE, Kumada H, et al
    Safety analysis of glecaprevir/pibrentasvir in patients with markers of advanced liver disease in clinical and real-world cohorts.
    J Viral Hepat. 2022;29:1050-1061.
    PubMed         Abstract available

    PLoS One

  9. YEE LM, Shah SK, Grobman WA, Labellarte PZ, et al
    Identifying barriers and facilitators of the inclusion of pregnant individuals in hepatitis C treatment programs in the United States.
    PLoS One. 2022;17:e0277987.
    PubMed         Abstract available

  10. ABU EL-MAKAREM MA, Kamel MF, Mohamed AA, Ali HA, et al
    Down-regulation of hepatic expression of GHR/STAT5/IGF-1 signaling pathway fosters development and aggressiveness of HCV-related hepatocellular carcinoma: Crosstalk with Snail-1 and type 2 transforming growth factor-beta receptor.
    PLoS One. 2022;17:e0277266.
    PubMed         Abstract available

  11. NAGUIB M, Abdel-Razek W, Estaphan S, Abdelsameea E, et al
    Impact of prothrombin and factor V Leiden mutations on the progression of fibrosis in patients with chronic hepatitis C.
    PLoS One. 2022;17:e0276592.
    PubMed         Abstract available


  12. MYERS B, Bekki Y, Kozato A, Crismale JF, et al
    DCD Hepatitis C Virus-positive Donor Livers Can Achieve Favorable Outcomes With Liver Transplantation and Are Underutilized.
    Transplantation. 2022 Nov 7. pii: 00007890-990000000-00240.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.